Supplementary Figure S3 from Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer
Year: 2024
Type: supplementary-materials
Abstract: Figure S3. Patient-level concentration profile of bintrafusp alfa at Day 1 postdose.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4392385563